ID

26045

Descrição

Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Pharmacokinetics - Repeating form (Scheduled visits)

Palavras-chave

Versões (4)
  1. 05/10/2017 05/10/2017 -
  2. 16/10/2017 16/10/2017 -
  3. 23/10/2017 23/10/2017 -
  4. 03/01/2018 03/01/2018 -
Titular dos direitos

GlaxoSmithKline

Transferido a

5 de outubro de 2017

DOI

Para um pedido faça login.

Licença

Creative Commons BY-NC 3.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

  • Os mais recentes
  • Os mais antigos
  • Preferidos
  • Os mais recentes
    • Os mais recentes
    • Os mais antigos
    • Preferidos

Sem comentários

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Pharmacokinetics GSK study Chronic Coronary Heart Disease NCT00799903

Inglês

Pharmacokinetics GSK study Chronic Coronary Heart Disease NCT00799903

1 Formulários  
An unscheduled PK blood sample must be obtained within 72 hours of last dose
Descrição

An unscheduled PK blood sample must be obtained within 72 hours of last dose

1. Was a pharmacokinetic blood sample obtained?
Descrição

pharmacokinetic blood sample

Tipo de dados

boolean

If yes, date taken
Descrição

Date of blood sample

Tipo de dados

date

If yes, time taken
Descrição

Time of blood sample

Tipo de dados

time

If Yes, date of last investigational product dose prior to PK sample
Descrição

date of last investigational product dose prior to PK sample

Tipo de dados

date

If Yes, time of last investigational product dose prior to PK sample
Descrição

time of last investigational product dose prior to PK sample

Tipo de dados

time

Sample Identifier/Sample Number
Descrição

Sample Identifier and Sample Number are conditional. The study team must choose one for inclusion on the eCRF form.

Tipo de dados

text

Voltar ao início da página

Similar models

Pharmacokinetics GSK study Chronic Coronary Heart Disease NCT00799903

1 Formulários
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
An unscheduled PK blood sample must be obtained within 72 hours of last dose
pharmacokinetic blood sample
Item
1. Was a pharmacokinetic blood sample obtained?
boolean
Date of blood sample
Item
If yes, date taken
date
Time of blood sample
Item
If yes, time taken
time
date of last investigational product dose prior to PK sample
Item
If Yes, date of last investigational product dose prior to PK sample
date
time of last investigational product dose prior to PK sample
Item
If Yes, time of last investigational product dose prior to PK sample
time
Sample Identifier/Sample Number
Item
Sample Identifier/Sample Number
text
Voltar ao início da página 

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial